Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Czechia Denmark Italy Lithuania Portugal +1
  • Study on Early Rituximab Treatment for Children with Nephrotic Syndrome

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Croatia France Germany Greece Ireland +6
  • Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4
  • Study on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions

    Recruiting

    3 1 1
    Investigated drugs:
    Poland
  • Study on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms

    Recruiting

    2 1 1
    Investigated diseases:
    Denmark
  • Long‑Term Safety Study of S68587 in Patients with Advanced Lymphoid Leukemia Previously Treated with the Therapy

    Not yet recruiting

    3 1 1
    Investigated diseases:
    France
  • Long‑term immunity after MEASLES, COMBINATIONS WITH MUMPS AND RUBELLA, LIVE ATTENUATED vaccine given at 6 months in children

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Denmark
  • Short 5‑day versus 7‑day amoxicillin treatment in children aged 2‑17 with acute streptococcal pharyngotonsillitis: a phase III open‑label randomized trial

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Safety and pharmacodynamics of cangrelor in children (birth to 17 years) with congenital heart disease undergoing vascular procedures

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Austria Germany The Netherlands Portugal